XML 35 R4.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Operating expenses      
Research and development [1] $ 5,833 $ 11,327 $ 18,381
General and administrative [2] 3,734 3,412 7,078
Total operating expenses 9,567 14,739 25,459
Financing income, net (572) (794) (1,238)
Loss before income taxes 8,995 13,945 24,221
Income Tax expenses 0 0 0
Net loss for the year $ 8,995 $ 13,945 $ 24,221
Basic loss per Ordinary Share $ 0.018 $ 0.039 $ 0.103
Diluted loss per Ordinary Share $ 0.018 $ 0.039 $ 0.103
Weighted average number of Ordinary Shares outstanding, basic [3] 510,227,715 359,048,638 234,998,859
Weighted average number of Ordinary Shares outstanding, diluted [3] 510,227,715 359,048,638 234,998,859
[1] Includes expenses related to related parties of $1,014 thousand, $1,228 thousand and $1,324 thousand for the years ended December 31, 2025, 2024 and 2023, respectively. See Note 12.
[2] Includes expenses related to related parties of $1,312 thousand, $1,237 thousand and $3,069 thousand for the years ended December 31, 2025, 2024 and 2023, respectively. See Note 12.
[3] 1 American Depositary Share (ADS) represents 80 Ordinary Shares.